Transplantation for Myelodysplastic Syndrome in the Era of Hypomethylating Agents

Current Opinion in Hematology - United States
doi 10.1097/moh.0b013e32834ff562
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Haploidentical Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

A Phase II Study of Omacetaxine Mepesuccinate for Patients With Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia After Failure of Hypomethylating Agents

American Journal of Hematology
Hematology
2018English

Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes

Seminars in Oncology
OncologyHematology
2011English

Hypomethylating Agents in Combination With Histone Deacetylase Inhibitors in Higher Risk Myelodysplastic Syndromes: Is There a Light at the End of the Tunnel?

Cancer
Cancer ResearchOncology
2017English

Selinexor, a First-In-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients With Myelodysplastic Syndromes Refractory to Hypomethylating Agents

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Autologous Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2005English

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acta Haematologica Polonica
OncologyHematology
2018English

Stem Cell Transplantation in Pediatric Patients With Myelodysplastic Syndrome at a Single Institution

Acta Haematologica Polonica
OncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy